173 related articles for article (PubMed ID: 12219878)
1. Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril.
Preston RA; Alonso A; Panzitta D; Zhang P; Karara AH
Am J Hypertens; 2002 Sep; 15(9):816-22. PubMed ID: 12219878
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
White WB; Pitt B; Preston RA; Hanes V
Circulation; 2005 Sep; 112(13):1979-84. PubMed ID: 16186434
[TBL] [Abstract][Full Text] [Related]
3. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
Preston RA; Norris PM; Alonso AB; Ni P; Hanes V; Karara AH
Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.
White WB; Hanes V; Chauhan V; Pitt B
Hypertension; 2006 Aug; 48(2):246-53. PubMed ID: 16801478
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
Karara AH; Hanes V; Alonso A; Ni P; Poola N; Silang R; Blode H; Preston RA
J Clin Pharmacol; 2007 Oct; 47(10):1292-302. PubMed ID: 17906162
[TBL] [Abstract][Full Text] [Related]
6. Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
Preston RA; White WB; Pitt B; Bakris G; Norris PM; Hanes V
Am J Hypertens; 2005 Jun; 18(6):797-804. PubMed ID: 15925739
[TBL] [Abstract][Full Text] [Related]
7. Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.
Vitale C; Mammi C; Gambacciani M; Russo N; Spoletini I; Fini M; Volterrani M; Rosano GMC
Int J Cardiol; 2017 Jan; 227():217-221. PubMed ID: 27843051
[TBL] [Abstract][Full Text] [Related]
8. Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.
Paoletti AM; Cagnacci A; Di Carlo C; Orrù MM; Neri M; D'Alterio MN; Melis GB
Gynecol Endocrinol; 2015 May; 31(5):384-7. PubMed ID: 25703254
[TBL] [Abstract][Full Text] [Related]
9. Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism.
Palacios S; Foidart JM; Genazzani AR
Maturitas; 2006 Nov; 55(4):297-307. PubMed ID: 16949774
[TBL] [Abstract][Full Text] [Related]
10. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
Oelkers WH
Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of conventional vs. novel hormone replacement therapy on blood pressure in postmenopausal women.
Preston RA
Climacteric; 2009; 12 Suppl 1():66-70. PubMed ID: 19811245
[TBL] [Abstract][Full Text] [Related]
12. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
Lin SQ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Zhou YZ; Wang ML; Zhu J; Chen SR; Su H; Yang CS; Wang SH; Zhang YZ; Dong XJ
Climacteric; 2011 Aug; 14(4):472-81. PubMed ID: 21469973
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
14. Effects of the hormone therapy, drospirenone and 17-beta estradiol, on early morning blood pressure in postmenopausal women with hypertension.
White WB; Hanes V; Mallareddy M; Chauhan V
J Am Soc Hypertens; 2008; 2(1):20-7. PubMed ID: 20409881
[TBL] [Abstract][Full Text] [Related]
15. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
Rübig A
Climacteric; 2003 Oct; 6 Suppl 3():49-54. PubMed ID: 15018248
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined drospirenone with estradiol for hypertensive postmenopausal women: a systemic review and meta-analysis.
Zhao X; Zhang XF; Zhao Y; Lin X; Li NY; Paudel G; Wang QY; Zhang XW; Li XL; Yu J
Gynecol Endocrinol; 2016 Sep; 32(9):685-689. PubMed ID: 27176003
[TBL] [Abstract][Full Text] [Related]
17. Drospirenone, a progestogen with antimineralocorticoid properties: a short review.
Oelkers W
Mol Cell Endocrinol; 2004 Mar; 217(1-2):255-61. PubMed ID: 15134826
[TBL] [Abstract][Full Text] [Related]
18. Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats.
Borgo MV; Claudio ER; Silva FB; Romero WG; Gouvea SA; Moysés MR; Santos RL; Almeida SA; Podratz PL; Graceli JB; Abreu GR
Braz J Med Biol Res; 2016 Jan; 49(1):e4655. PubMed ID: 26577845
[TBL] [Abstract][Full Text] [Related]
19. Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate.
Junge W; El-Samalouti V; Gerlinger C; Schaefers M
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):195-200. PubMed ID: 19879683
[TBL] [Abstract][Full Text] [Related]
20. Drospirenone with 17beta-estradiol in the postmenopausal woman with hypertension.
White WB
Climacteric; 2007 Feb; 10 Suppl 1():25-31. PubMed ID: 17364595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
